vs Medical Therapy = Results from NEJM 2010 Oct randomized trials vs SAVR or Vs SAVR =NEJM medical 2011 June therapy
Still needed Predictors of outcomes Need for more accurate & reliable risk scores
What data is still missing?
Provide comparisons between TAVI & SAVR in patients foreligibility whom either Expanded studies procedure wouldpathology, be (e.g. bicuspid aortic regurgitation) suitable (NICE)
Still research need Objective & to clearly define patient reproducible criteria for (in)operability selection criteria (NICE)
1 follow-up for 3.5 years
Durability results Valve at 5 y & More long-term patient outcome at data needed: stroke, >2 y
aortic regurgitation, symptom relief, valve durability (NICE) Better survival (2y) transfemoral Best approach? approach (UK Best device? Registry) Best device?
Cost available Costdata and costeffectiveness (France) data CEA (no-modeling) still lacking